Announcements Trials
Browse Landscape

Phase

Phase NA 52Phase 2 6Phase 3 4Phase 4 3

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 2Gynecologic 1Endocrine 1

Conditions

Obesity 2Weight Loss 1Sexual Dysfunction, Physiological 1Protein Deficiency 1Overweight 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Malnutrition 1Inflammation 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Nutrition Assessment × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT04687124 2020-12-29

EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy -

University of Copenhagen

Phase 4 Unknown
26 enrolled

Protein Deficiency, Weight Loss, Malnutrition

NCT01554735 2015-07-29

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

Changi General Hospital

Phase 4 Completed
70 enrolled
EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡